Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by longondmxon Jul 27, 2009 10:18am
484 Views
Post# 16168124

RE: RE: Where we've come from

RE: RE: Where we've come fromThe $14 was during a time when valuations were overly optimistic for all stocks.  I remember buying shares one day for a no-name tech company that had a big idea only and seeing the stock double within days. Then the bubble burst.

But then again, valuing NRI at $2 today pre-FDA approval wouldn't be too far fecthed given that it would equate to the cost to bring a drug to market.  That's why I think post-FDA we will see $1.50-$2 a share.

Bullboard Posts